Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease

被引：0
|
作者：
Kyohei Isshiki
Takahiro Kamiya
Akifumi Endo
Kentaro Okamoto
Tomoo Osumi
Toshinao Kawai
Katsuhiro Arai
Daisuke Tomizawa
Kazuo Ohtsuka
Masakazu Nagahori
Kohsuke Imai
Motohiro Kato
Hirokazu Kanegane
机构：
[1] National Center for Child Health and Development,Children’s Cancer Center
[2] Tokyo Medical and Dental University Hospital,Department of Pediatrics
[3] Tokyo Medical and Dental University Hospital,Department of Pediatric Surgery
[4] National Center for Child Health and Development,Division of Immunology
[5] National Center for Child Health and Development,Division of Gastroenterology
[6] Tokyo Medical and Dental University Hospital,Department of Gastroenterology and Hepatology
来源：
International Journal of Hematology | 2022年 / 115卷
关键词：
Vedolizumab; GVHD; Children; Gastrointestinal tract; Refractory;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Vedolizumab, an immunosuppressive drug that acts locally on the gastrointestinal tract, is mainly used for the treatment of inflammatory bowel disease, and has been reported to be effective against gastrointestinal acute graft-versus-host disease (GI-aGVHD) in adults. However, there is insufficient evidence for pediatric GI-aGVHD. We used vedolizumab to treat three cases of GI-aGVHD in patients aged 1.5–4.4 years. It was significantly effective in two patients and did not cause serious side effects in any patient. Vedolizumab might be effective and safe for pediatric GI-aGVHD refractory to other treatments, but this must be confirmed in future studies.
引用
收藏
页码：590 / 594
页数：4
相关论文
共 50 条
  • [21] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
  • [22] Novel strategies for steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Vogelsang, GB
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 40 - 44
  • [23] Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease
    Kim, Hyun Min
    Lee, Joonyeop
    Kim, Seokjin
    Lee, Jong Wook
    Kim, Hee-Je
    Cho, Young-Seok
    BLOOD RESEARCH, 2023, 58 (03) : 145 - 148
  • [24] The use of vedolizumab as second-line therapy for steroid-refractory gastrointestinal acute graft-versus host disease in children
    Bronin, G.
    Zhuravel, M.
    Lifshits, A.
    Seregin, G.
    Zhuravel, E.
    Kurmanov, B.
    Taishikhina, I.
    Burtsev, E.
    Kumirova, E.
    Maschan, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 194 - 194
  • [25] Efficacy of Mesenchymal Stem Cells for Pediatric Steroid-Refractory Acute Graft-Versus-Host Disease
    Kubota, Hirohito
    Arakawa, Yuki
    Irikura, Tomoya
    Watakabe, Mai
    Honda, Mamoru
    Mitani, Yuichi
    Oshima, Koichi
    Mori, Makiko
    Fukuoka, Kohei
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [26] VEDOLIZUMAB IN STEROID REFRACTORY INTESTINAL GRAFT-VERSUS-HOST DISEASE
    Myhre, A. E.
    Kristiansen, J. D.
    Lundin, K. E. A.
    Osnes, L. T. N.
    Warren, D. J.
    Tjonnfjord, G. E.
    Gedde-Dahl, T.
    Floisand, Y.
    HAEMATOLOGICA, 2017, 102 : 611 - 612
  • [27] Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease
    van Groningen, Lenneke F. J.
    Liefferink, Aleida M.
    de Haan, Anton F. J.
    Schaap, Nicolaas P. M.
    Donnelly, J. Peter
    Blijlevens, Nicole M. A.
    van der Velden, Walter J. F. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 179 - 182
  • [28] Extracorporeal photopheresis in combined immunosuppressive therapy of steroid-refractory acute graft-versus-host disease
    Kozlov, A.
    Bykova, T.
    Kulagina, I.
    Kochina, E.
    Estrina, M.
    Stancheva, N.
    Kazantsev, I.
    Zubarovskaya, L.
    Punanov, Y.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S160 - S161
  • [29] EFFICACY AND SAFETY OF INFLIXIMAB THERAPY IN THE SETTING OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    Halahleh, Khalid
    Al Shurman, Jana
    Taqash, Ayat
    Ma'koseh, Mohammad
    Abu Khader, Ahmad
    Muradi, Isra
    Da'na, Waleed
    Rihani, Rawad
    BONE MARROW TRANSPLANTATION, 2024, 59 : 340 - 341
  • [30] COMBINATION THERAPY WITH INOLIMOMAB AND ETANERCEPT FOR SEVERE STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    Van Groningen, L.
    Liefferink, A.
    de Haan, A.
    Schaap, N.
    Donnelly, P.
    Blijlevens, N.
    van der Velden, W.
    HAEMATOLOGICA, 2015, 100 : 279 - 279
12345